Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Something to think about...
View:
Post by EbbFlow88 on Jan 03, 2023 4:07pm

Something to think about...

Something I can't stop thinking about is that the current market cap is around $585M assuming 112.5M shares outstanding at the current price.

Biotoscana was purchased for $369M CAD and Exelon was purchased for $217M CAD. Neither of which was purchased at a high multiple. Total purchases of those two assets = $586M

Excluding the recent debt deal, substract cash + equivalents and financial assets from Mcap and you get ~290M CAD for GBT and drugs.

585 - 145 - 150 = 290M

So, at today's price, buyers are getting those assets at $0.50 on the dollar for what was paid, which our frugal management team deemed worth the purchase. 

Also, ~45M in cash from Ops is a return on that 290M of 15.5%

Either they way overpaid for those assets (as chianchin most definitely believes) or this is an unbelievable gift from the market. My money is on the latter.
Comment by Chianchin on Jan 03, 2023 4:39pm
The only reason GUD maintains that market cap is the buy back that will soon ents as GUD had to borrow monopoly latam money. as son the cash runs out GUD share price will trade below $2 and the market know. GUD cannot make ever a profit in LTAM with generics drugs. Companies who are out of Latam too cannot make a profit not GUD is going to make it in Latam? Shake your head mugsy/ebflow as evryone ...more  
Comment by EbbFlow88 on Jan 10, 2023 2:35pm
If you believe that tthe tax assessment will go our way. You can add  46M to our cash total. Making the market value of the base operations  ~$250M which yields 18% cash. Separately, there has been no filings for stock buybacks last month. Usually, at this point in the following month that has been filed. Maybe it's late or maybe we stopped buying back shares.  No question ...more  
Comment by MrMugsy on Jan 10, 2023 3:46pm
Some kind of deal - even if it's small would seem logical in 2023. I know a small pharma that's getting regular requests to tie up for their heavy bank account and that's only $42 MM. Thinking, GUD should be able to work this environment to their favor and pick up some assets. Let's see.
Comment by Chianchin on Jan 10, 2023 5:07pm
Yep making money on people who are making $2 dollars a day and fighting for $5, are you dumb, deaft,  blind and callus to the human tragedies takiing place in LATAM?   Hundreds of people died in Peru yesterday, of 1500 people arested in Brazilia and scores injured just for starter. What a mouth piece of fermented sht
Comment by EbbFlow88 on Jan 10, 2023 5:42pm
That was timely! So they repurchased another 450k shares in December.
Comment by Chianchin on Jan 10, 2023 6:18pm
..and to be able do that they borrowed 32 millions dollars of worthless of monopolyLatam money paper depretiating @ 10% per months. When they can no loger borrow soon the share price will sink to $ 2 or less. Are you that inepth mugys boy alias.?
Comment by MrMugsy on Jan 10, 2023 6:58pm
Yes they did ! Almost half a million. Filed 2023-01-10 11:59   Tx date 2022-12-21 $GUD Knight Therapeutics Inc. Knight Therapeutics Inc. 1 - Issuer Direct Ownership Common Shares 38 - Redemption, retraction, cancellation, repurchase $7,860 +1,500 vol $5.24 each  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities